Impact on 30-d readmissions for cirrhotic patients with ascites after an educational intervention: A pilot study

Table 2 Baseline characteristics, n (%)

Groups	Control (n = 39)	Intervention (n = 46)	P value
Female	18 (46.2)	19 (41.3)	0.7
Age, yr	51.9 (11.4)	54.9 (10.9)	0.2
Hepatology consult	22 (56.41)	30 (65.22)	0.4
MELD-Na score	25.5 (6.2)	26.1 (7.7)	0.7
Comorbidities
CAD	3 (7.69)	4 (8.7)	0.9
CKD	25 (64.1)	39 (84.78)	0.03
DM	11 (28.21)	17 (36.96)	0.4
HD	11 (28.21)	16 (34.78)	0.5
HIV	3 (7.69)	0 (0)	0.06
PVT	5 (12.82)	6 (13.04)	1
Etiology of cirrhosis			0.3
ETOH	23 (58.97)	21 (45.65)
Hepatitis C	1 (2.56)	5 (10.87)
ETOH/Hep C	3 (7.69)	2 (4.35)
Hepatitis B	3 (7.69)	1 (2.17)
NASH	4 (10.26)	8 (17.39)
Other	5 (12.82)	9 (19.57)

MELD-Na: Model of end-stage liver disease-sodium; CAD: Coronary artery disease; CKD: Chronic kidney disease; DM: Diabetes mellitus; HD: Hemodialysis; HIV: Human immunodeficiency virus; PVT: Portal vein thrombosis; ETOH: Alcohol; NASH: Non-alcoholic steatohepatitis.